Dyne Therapeutics
Clinical trials sponsored by Dyne Therapeutics, explained in plain language.
-
New drug DYNE-101 aims to ease muscle stiffness in rare disease
Disease control Recruiting nowThis study tests a new drug, DYNE-101, in 116 adults with myotonic dystrophy type 1 (DM1), a condition that causes muscle weakness and stiffness. The main goal is to see if the drug is safe and tolerable, and to measure its effects on muscle function and disease markers. Particip…
Phase: PHASE1, PHASE2 • Sponsor: Dyne Therapeutics • Aim: Disease control
Last updated May 26, 2026 09:33 UTC
-
New drug trial hopes to ease muscle stiffness in rare disease
Disease control Recruiting nowThis study tests a new medicine, DYNE-101, for adults with myotonic dystrophy type 1, a condition that causes muscle weakness and stiffness. About 150 people will receive either the drug or a placebo for 48 weeks. The goal is to see if the drug improves muscle function, like stan…
Phase: PHASE3 • Sponsor: Dyne Therapeutics • Aim: Disease control
Last updated May 20, 2026 11:57 UTC